https://info.adarepharmasolutions.com/newsroom Make sure you are up to speed with all the latest happenings here at Adare Pharma Solutions by checking out our newsroom! en Wed, 29 Apr 2026 09:14:00 GMT 2026-04-29T09:14:00Z en https://info.adarepharmasolutions.com/newsroom/achieve-life-sciences-announces-operational-progress-including-completion-of-technology-transfer-to-adare-pharma-solutions-test-4 <div class="hs-featured-image-wrapper"> <a href="https://info.adarepharmasolutions.com/newsroom/achieve-life-sciences-announces-operational-progress-including-completion-of-technology-transfer-to-adare-pharma-solutions-test-4" title="" class="hs-featured-image-link"> <img src="https://info.adarepharmasolutions.com/hubfs/Achieve%20Life%20Sciences%20Announces%20Operational%20Progress%20Including%20Completion%20of%20Technology%20Transfer%20to%20Adare%20Pharma%20Solutions%20(1).png" alt="Achieve Life Sciences Announces Operational Progress Including Completion of Technology Transfer to Adare Pharma Solutions test 4" class="hs-featured-image" style="width:auto !important; max-width:50%; float:left; margin:0 15px 15px 0;"> </a> </div> <p style="line-height: 1.6;">Achieve Life Sciences, Inc. (Achieve or the Company) (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline as a treatment of nicotine dependence, today announced significant operational progress including the transfer of cytisinicline manufacturing to U.S.-based Adare Pharma Solutions (Adare). Achieve has now completed the analytical method transfer to Adare’s manufacturing facility in Vandalia, Ohio. Completion of these activities ensures that all testing procedures are fully qualified at the site, maintaining the highest standards of quality control and regulatory compliance.</p> <div class="hs-featured-image-wrapper"> <a href="https://info.adarepharmasolutions.com/newsroom/achieve-life-sciences-announces-operational-progress-including-completion-of-technology-transfer-to-adare-pharma-solutions-test-4" title="" class="hs-featured-image-link"> <img src="https://info.adarepharmasolutions.com/hubfs/Achieve%20Life%20Sciences%20Announces%20Operational%20Progress%20Including%20Completion%20of%20Technology%20Transfer%20to%20Adare%20Pharma%20Solutions%20(1).png" alt="Achieve Life Sciences Announces Operational Progress Including Completion of Technology Transfer to Adare Pharma Solutions test 4" class="hs-featured-image" style="width:auto !important; max-width:50%; float:left; margin:0 15px 15px 0;"> </a> </div> <p style="line-height: 1.6;">Achieve Life Sciences, Inc. (Achieve or the Company) (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline as a treatment of nicotine dependence, today announced significant operational progress including the transfer of cytisinicline manufacturing to U.S.-based Adare Pharma Solutions (Adare). Achieve has now completed the analytical method transfer to Adare’s manufacturing facility in Vandalia, Ohio. Completion of these activities ensures that all testing procedures are fully qualified at the site, maintaining the highest standards of quality control and regulatory compliance.</p> <img src="https://track.hubspot.com/__ptq.gif?a=50417852&amp;k=14&amp;r=https%3A%2F%2Finfo.adarepharmasolutions.com%2Fnewsroom%2Fachieve-life-sciences-announces-operational-progress-including-completion-of-technology-transfer-to-adare-pharma-solutions-test-4&amp;bu=https%253A%252F%252Finfo.adarepharmasolutions.com%252Fnewsroom&amp;bvt=rss" alt="" width="1" height="1" style="min-height:1px!important;width:1px!important;border-width:0!important;margin-top:0!important;margin-bottom:0!important;margin-right:0!important;margin-left:0!important;padding-top:0!important;padding-bottom:0!important;padding-right:0!important;padding-left:0!important; "> Articles Wed, 29 Apr 2026 09:14:00 GMT https://info.adarepharmasolutions.com/newsroom/achieve-life-sciences-announces-operational-progress-including-completion-of-technology-transfer-to-adare-pharma-solutions-test-4 2026-04-29T09:14:00Z Adare Pharma Solutions https://info.adarepharmasolutions.com/newsroom/achieve-life-sciences-announces-operational-progress-including-completion-of-technology-transfer-to-adare-pharma-solutions-test-3 <div class="hs-featured-image-wrapper"> <a href="https://info.adarepharmasolutions.com/newsroom/achieve-life-sciences-announces-operational-progress-including-completion-of-technology-transfer-to-adare-pharma-solutions-test-3" title="" class="hs-featured-image-link"> <img src="https://info.adarepharmasolutions.com/hubfs/Achieve%20Life%20Sciences%20Announces%20Operational%20Progress%20Including%20Completion%20of%20Technology%20Transfer%20to%20Adare%20Pharma%20Solutions%20(1).png" alt="Achieve Life Sciences Announces Operational Progress Including Completion of Technology Transfer to Adare Pharma Solutions test 3" class="hs-featured-image" style="width:auto !important; max-width:50%; float:left; margin:0 15px 15px 0;"> </a> </div> <p style="line-height: 1.6;">Achieve Life Sciences, Inc. (Achieve or the Company) (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline as a treatment of nicotine dependence, today announced significant operational progress including the transfer of cytisinicline manufacturing to U.S.-based Adare Pharma Solutions (Adare). Achieve has now completed the analytical method transfer to Adare’s manufacturing facility in Vandalia, Ohio. Completion of these activities ensures that all testing procedures are fully qualified at the site, maintaining the highest standards of quality control and regulatory compliance.</p> <div class="hs-featured-image-wrapper"> <a href="https://info.adarepharmasolutions.com/newsroom/achieve-life-sciences-announces-operational-progress-including-completion-of-technology-transfer-to-adare-pharma-solutions-test-3" title="" class="hs-featured-image-link"> <img src="https://info.adarepharmasolutions.com/hubfs/Achieve%20Life%20Sciences%20Announces%20Operational%20Progress%20Including%20Completion%20of%20Technology%20Transfer%20to%20Adare%20Pharma%20Solutions%20(1).png" alt="Achieve Life Sciences Announces Operational Progress Including Completion of Technology Transfer to Adare Pharma Solutions test 3" class="hs-featured-image" style="width:auto !important; max-width:50%; float:left; margin:0 15px 15px 0;"> </a> </div> <p style="line-height: 1.6;">Achieve Life Sciences, Inc. (Achieve or the Company) (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline as a treatment of nicotine dependence, today announced significant operational progress including the transfer of cytisinicline manufacturing to U.S.-based Adare Pharma Solutions (Adare). Achieve has now completed the analytical method transfer to Adare’s manufacturing facility in Vandalia, Ohio. Completion of these activities ensures that all testing procedures are fully qualified at the site, maintaining the highest standards of quality control and regulatory compliance.</p> <img src="https://track.hubspot.com/__ptq.gif?a=50417852&amp;k=14&amp;r=https%3A%2F%2Finfo.adarepharmasolutions.com%2Fnewsroom%2Fachieve-life-sciences-announces-operational-progress-including-completion-of-technology-transfer-to-adare-pharma-solutions-test-3&amp;bu=https%253A%252F%252Finfo.adarepharmasolutions.com%252Fnewsroom&amp;bvt=rss" alt="" width="1" height="1" style="min-height:1px!important;width:1px!important;border-width:0!important;margin-top:0!important;margin-bottom:0!important;margin-right:0!important;margin-left:0!important;padding-top:0!important;padding-bottom:0!important;padding-right:0!important;padding-left:0!important; "> Articles Wed, 29 Apr 2026 09:13:30 GMT https://info.adarepharmasolutions.com/newsroom/achieve-life-sciences-announces-operational-progress-including-completion-of-technology-transfer-to-adare-pharma-solutions-test-3 2026-04-29T09:13:30Z Adare Pharma Solutions https://info.adarepharmasolutions.com/newsroom/achieve-life-sciences-announces-operational-progress-including-completion-of-technology-transfer-to-adare-pharma-solutions-test-2 <div class="hs-featured-image-wrapper"> <a href="https://info.adarepharmasolutions.com/newsroom/achieve-life-sciences-announces-operational-progress-including-completion-of-technology-transfer-to-adare-pharma-solutions-test-2" title="" class="hs-featured-image-link"> <img src="https://info.adarepharmasolutions.com/hubfs/Achieve%20Life%20Sciences%20Announces%20Operational%20Progress%20Including%20Completion%20of%20Technology%20Transfer%20to%20Adare%20Pharma%20Solutions%20(1).png" alt="Achieve Life Sciences Announces Operational Progress Including Completion of Technology Transfer to Adare Pharma Solutions test 2" class="hs-featured-image" style="width:auto !important; max-width:50%; float:left; margin:0 15px 15px 0;"> </a> </div> <p style="line-height: 1.6;">Achieve Life Sciences, Inc. (Achieve or the Company) (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline as a treatment of nicotine dependence, today announced significant operational progress including the transfer of cytisinicline manufacturing to U.S.-based Adare Pharma Solutions (Adare). Achieve has now completed the analytical method transfer to Adare’s manufacturing facility in Vandalia, Ohio. Completion of these activities ensures that all testing procedures are fully qualified at the site, maintaining the highest standards of quality control and regulatory compliance.</p> <div class="hs-featured-image-wrapper"> <a href="https://info.adarepharmasolutions.com/newsroom/achieve-life-sciences-announces-operational-progress-including-completion-of-technology-transfer-to-adare-pharma-solutions-test-2" title="" class="hs-featured-image-link"> <img src="https://info.adarepharmasolutions.com/hubfs/Achieve%20Life%20Sciences%20Announces%20Operational%20Progress%20Including%20Completion%20of%20Technology%20Transfer%20to%20Adare%20Pharma%20Solutions%20(1).png" alt="Achieve Life Sciences Announces Operational Progress Including Completion of Technology Transfer to Adare Pharma Solutions test 2" class="hs-featured-image" style="width:auto !important; max-width:50%; float:left; margin:0 15px 15px 0;"> </a> </div> <p style="line-height: 1.6;">Achieve Life Sciences, Inc. (Achieve or the Company) (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline as a treatment of nicotine dependence, today announced significant operational progress including the transfer of cytisinicline manufacturing to U.S.-based Adare Pharma Solutions (Adare). Achieve has now completed the analytical method transfer to Adare’s manufacturing facility in Vandalia, Ohio. Completion of these activities ensures that all testing procedures are fully qualified at the site, maintaining the highest standards of quality control and regulatory compliance.</p> <img src="https://track.hubspot.com/__ptq.gif?a=50417852&amp;k=14&amp;r=https%3A%2F%2Finfo.adarepharmasolutions.com%2Fnewsroom%2Fachieve-life-sciences-announces-operational-progress-including-completion-of-technology-transfer-to-adare-pharma-solutions-test-2&amp;bu=https%253A%252F%252Finfo.adarepharmasolutions.com%252Fnewsroom&amp;bvt=rss" alt="" width="1" height="1" style="min-height:1px!important;width:1px!important;border-width:0!important;margin-top:0!important;margin-bottom:0!important;margin-right:0!important;margin-left:0!important;padding-top:0!important;padding-bottom:0!important;padding-right:0!important;padding-left:0!important; "> Articles Wed, 29 Apr 2026 09:12:59 GMT https://info.adarepharmasolutions.com/newsroom/achieve-life-sciences-announces-operational-progress-including-completion-of-technology-transfer-to-adare-pharma-solutions-test-2 2026-04-29T09:12:59Z Adare Pharma Solutions https://info.adarepharmasolutions.com/newsroom/achieve-life-sciences-announces-operational-progress-including-completion-of-technology-transfer-to-adare-pharma-solutions-test-1 <div class="hs-featured-image-wrapper"> <a href="https://info.adarepharmasolutions.com/newsroom/achieve-life-sciences-announces-operational-progress-including-completion-of-technology-transfer-to-adare-pharma-solutions-test-1" title="" class="hs-featured-image-link"> <img src="https://info.adarepharmasolutions.com/hubfs/Achieve%20Life%20Sciences%20Announces%20Operational%20Progress%20Including%20Completion%20of%20Technology%20Transfer%20to%20Adare%20Pharma%20Solutions%20(1).png" alt="Achieve Life Sciences Announces Operational Progress Including Completion of Technology Transfer to Adare Pharma Solutions test 1" class="hs-featured-image" style="width:auto !important; max-width:50%; float:left; margin:0 15px 15px 0;"> </a> </div> <p style="line-height: 1.6;">Achieve Life Sciences, Inc. (Achieve or the Company) (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline as a treatment of nicotine dependence, today announced significant operational progress including the transfer of cytisinicline manufacturing to U.S.-based Adare Pharma Solutions (Adare). Achieve has now completed the analytical method transfer to Adare’s manufacturing facility in Vandalia, Ohio. Completion of these activities ensures that all testing procedures are fully qualified at the site, maintaining the highest standards of quality control and regulatory compliance.</p> <div class="hs-featured-image-wrapper"> <a href="https://info.adarepharmasolutions.com/newsroom/achieve-life-sciences-announces-operational-progress-including-completion-of-technology-transfer-to-adare-pharma-solutions-test-1" title="" class="hs-featured-image-link"> <img src="https://info.adarepharmasolutions.com/hubfs/Achieve%20Life%20Sciences%20Announces%20Operational%20Progress%20Including%20Completion%20of%20Technology%20Transfer%20to%20Adare%20Pharma%20Solutions%20(1).png" alt="Achieve Life Sciences Announces Operational Progress Including Completion of Technology Transfer to Adare Pharma Solutions test 1" class="hs-featured-image" style="width:auto !important; max-width:50%; float:left; margin:0 15px 15px 0;"> </a> </div> <p style="line-height: 1.6;">Achieve Life Sciences, Inc. (Achieve or the Company) (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline as a treatment of nicotine dependence, today announced significant operational progress including the transfer of cytisinicline manufacturing to U.S.-based Adare Pharma Solutions (Adare). Achieve has now completed the analytical method transfer to Adare’s manufacturing facility in Vandalia, Ohio. Completion of these activities ensures that all testing procedures are fully qualified at the site, maintaining the highest standards of quality control and regulatory compliance.</p> <img src="https://track.hubspot.com/__ptq.gif?a=50417852&amp;k=14&amp;r=https%3A%2F%2Finfo.adarepharmasolutions.com%2Fnewsroom%2Fachieve-life-sciences-announces-operational-progress-including-completion-of-technology-transfer-to-adare-pharma-solutions-test-1&amp;bu=https%253A%252F%252Finfo.adarepharmasolutions.com%252Fnewsroom&amp;bvt=rss" alt="" width="1" height="1" style="min-height:1px!important;width:1px!important;border-width:0!important;margin-top:0!important;margin-bottom:0!important;margin-right:0!important;margin-left:0!important;padding-top:0!important;padding-bottom:0!important;padding-right:0!important;padding-left:0!important; "> Articles Wed, 29 Apr 2026 09:12:32 GMT https://info.adarepharmasolutions.com/newsroom/achieve-life-sciences-announces-operational-progress-including-completion-of-technology-transfer-to-adare-pharma-solutions-test-1 2026-04-29T09:12:32Z Adare Pharma Solutions https://info.adarepharmasolutions.com/newsroom/newsroom-post-1-clone <div class="hs-featured-image-wrapper"> <a href="https://info.adarepharmasolutions.com/newsroom/newsroom-post-1-clone" title="" class="hs-featured-image-link"> <img src="https://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Videos/Microcaps%C2%AE%20Technology.png" alt="Newsroom post 1 (Clone)" class="hs-featured-image" style="width:auto !important; max-width:50%; float:left; margin:0 15px 15px 0;"> </a> </div> <p><span style="text-align: justify;">It is a long established fact that a reader will be distracted by the readable content of a page when looking at its layout. The point of using Lorem Ipsum is that it has a more-or-less normal distribution of letters, as opposed to using 'Content here, content here', making it look like readable English. Many desktop publishing packages and web page editors now use Lorem Ipsum as their default model text, and a search for 'lorem ipsum' will uncover many web sites still in their infancy.</span></p> <div class="hs-featured-image-wrapper"> <a href="https://info.adarepharmasolutions.com/newsroom/newsroom-post-1-clone" title="" class="hs-featured-image-link"> <img src="https://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Videos/Microcaps%C2%AE%20Technology.png" alt="Newsroom post 1 (Clone)" class="hs-featured-image" style="width:auto !important; max-width:50%; float:left; margin:0 15px 15px 0;"> </a> </div> <p><span style="text-align: justify;">It is a long established fact that a reader will be distracted by the readable content of a page when looking at its layout. The point of using Lorem Ipsum is that it has a more-or-less normal distribution of letters, as opposed to using 'Content here, content here', making it look like readable English. Many desktop publishing packages and web page editors now use Lorem Ipsum as their default model text, and a search for 'lorem ipsum' will uncover many web sites still in their infancy.</span></p> <img src="https://track.hubspot.com/__ptq.gif?a=50417852&amp;k=14&amp;r=https%3A%2F%2Finfo.adarepharmasolutions.com%2Fnewsroom%2Fnewsroom-post-1-clone&amp;bu=https%253A%252F%252Finfo.adarepharmasolutions.com%252Fnewsroom&amp;bvt=rss" alt="" width="1" height="1" style="min-height:1px!important;width:1px!important;border-width:0!important;margin-top:0!important;margin-bottom:0!important;margin-right:0!important;margin-left:0!important;padding-top:0!important;padding-bottom:0!important;padding-right:0!important;padding-left:0!important; "> Articles Wed, 29 Apr 2026 07:39:58 GMT https://info.adarepharmasolutions.com/newsroom/newsroom-post-1-clone 2026-04-29T07:39:58Z Adare Pharma Solutions https://info.adarepharmasolutions.com/newsroom/achieve-life-sciences-announces-operational-progress-including-completion-of-technology-transfer-to-adare-pharma-solutions-test <div class="hs-featured-image-wrapper"> <a href="https://info.adarepharmasolutions.com/newsroom/achieve-life-sciences-announces-operational-progress-including-completion-of-technology-transfer-to-adare-pharma-solutions-test" title="" class="hs-featured-image-link"> <img src="https://info.adarepharmasolutions.com/hubfs/Achieve%20Life%20Sciences%20Announces%20Operational%20Progress%20Including%20Completion%20of%20Technology%20Transfer%20to%20Adare%20Pharma%20Solutions%20(1).png" alt="Achieve Life Sciences Announces Operational Progress Including Completion of Technology Transfer to Adare Pharma Solutions test" class="hs-featured-image" style="width:auto !important; max-width:50%; float:left; margin:0 15px 15px 0;"> </a> </div> <p style="line-height: 1.6;">Achieve Life Sciences, Inc. (Achieve or the Company) (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline as a treatment of nicotine dependence, today announced significant operational progress including the transfer of cytisinicline manufacturing to U.S.-based Adare Pharma Solutions (Adare). Achieve has now completed the analytical method transfer to Adare’s manufacturing facility in Vandalia, Ohio. Completion of these activities ensures that all testing procedures are fully qualified at the site, maintaining the highest standards of quality control and regulatory compliance.</p> <div class="hs-featured-image-wrapper"> <a href="https://info.adarepharmasolutions.com/newsroom/achieve-life-sciences-announces-operational-progress-including-completion-of-technology-transfer-to-adare-pharma-solutions-test" title="" class="hs-featured-image-link"> <img src="https://info.adarepharmasolutions.com/hubfs/Achieve%20Life%20Sciences%20Announces%20Operational%20Progress%20Including%20Completion%20of%20Technology%20Transfer%20to%20Adare%20Pharma%20Solutions%20(1).png" alt="Achieve Life Sciences Announces Operational Progress Including Completion of Technology Transfer to Adare Pharma Solutions test" class="hs-featured-image" style="width:auto !important; max-width:50%; float:left; margin:0 15px 15px 0;"> </a> </div> <p style="line-height: 1.6;">Achieve Life Sciences, Inc. (Achieve or the Company) (Nasdaq: ACHV), a late-stage specialty pharmaceutical company focused on the global development and commercialization of cytisinicline as a treatment of nicotine dependence, today announced significant operational progress including the transfer of cytisinicline manufacturing to U.S.-based Adare Pharma Solutions (Adare). Achieve has now completed the analytical method transfer to Adare’s manufacturing facility in Vandalia, Ohio. Completion of these activities ensures that all testing procedures are fully qualified at the site, maintaining the highest standards of quality control and regulatory compliance.</p> <img src="https://track.hubspot.com/__ptq.gif?a=50417852&amp;k=14&amp;r=https%3A%2F%2Finfo.adarepharmasolutions.com%2Fnewsroom%2Fachieve-life-sciences-announces-operational-progress-including-completion-of-technology-transfer-to-adare-pharma-solutions-test&amp;bu=https%253A%252F%252Finfo.adarepharmasolutions.com%252Fnewsroom&amp;bvt=rss" alt="" width="1" height="1" style="min-height:1px!important;width:1px!important;border-width:0!important;margin-top:0!important;margin-bottom:0!important;margin-right:0!important;margin-left:0!important;padding-top:0!important;padding-bottom:0!important;padding-right:0!important;padding-left:0!important; "> Articles Wed, 29 Apr 2026 07:35:21 GMT https://info.adarepharmasolutions.com/newsroom/achieve-life-sciences-announces-operational-progress-including-completion-of-technology-transfer-to-adare-pharma-solutions-test 2026-04-29T07:35:21Z Adare Pharma Solutions https://info.adarepharmasolutions.com/newsroom/newsroom-post-1 <div class="hs-featured-image-wrapper"> <a href="https://info.adarepharmasolutions.com/newsroom/newsroom-post-1" title="" class="hs-featured-image-link"> <img src="https://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Videos/Microcaps%C2%AE%20Technology.png" alt="Newsroom post 1" class="hs-featured-image" style="width:auto !important; max-width:50%; float:left; margin:0 15px 15px 0;"> </a> </div> <p><span style="text-align: justify;">It is a long established fact that a reader will be distracted by the readable content of a page when looking at its layout. The point of using Lorem Ipsum is that it has a more-or-less normal distribution of letters, as opposed to using 'Content here, content here', making it look like readable English. Many desktop publishing packages and web page editors now use Lorem Ipsum as their default model text, and a search for 'lorem ipsum' will uncover many web sites still in their infancy.</span></p> <div class="hs-featured-image-wrapper"> <a href="https://info.adarepharmasolutions.com/newsroom/newsroom-post-1" title="" class="hs-featured-image-link"> <img src="https://info.adarepharmasolutions.com/hubfs/Resource%20Center/Featured%20Images/Videos/Microcaps%C2%AE%20Technology.png" alt="Newsroom post 1" class="hs-featured-image" style="width:auto !important; max-width:50%; float:left; margin:0 15px 15px 0;"> </a> </div> <p><span style="text-align: justify;">It is a long established fact that a reader will be distracted by the readable content of a page when looking at its layout. The point of using Lorem Ipsum is that it has a more-or-less normal distribution of letters, as opposed to using 'Content here, content here', making it look like readable English. Many desktop publishing packages and web page editors now use Lorem Ipsum as their default model text, and a search for 'lorem ipsum' will uncover many web sites still in their infancy.</span></p> <img src="https://track.hubspot.com/__ptq.gif?a=50417852&amp;k=14&amp;r=https%3A%2F%2Finfo.adarepharmasolutions.com%2Fnewsroom%2Fnewsroom-post-1&amp;bu=https%253A%252F%252Finfo.adarepharmasolutions.com%252Fnewsroom&amp;bvt=rss" alt="" width="1" height="1" style="min-height:1px!important;width:1px!important;border-width:0!important;margin-top:0!important;margin-bottom:0!important;margin-right:0!important;margin-left:0!important;padding-top:0!important;padding-bottom:0!important;padding-right:0!important;padding-left:0!important; "> Articles Mon, 27 Apr 2026 14:43:32 GMT https://info.adarepharmasolutions.com/newsroom/newsroom-post-1 2026-04-27T14:43:32Z Adare Pharma Solutions